Sovleplenib is an investigational new drug that is being evaluated by Hutchison MediPharma for the treatment of immune thrombocytopenia (ITP) and warm antibody autoimmune hemolytic anemia (WAIHA).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.